92 related articles for article (PubMed ID: 20483605)
1. Discovery of a novel series of CXCR3 antagonists.
Crosignani S; Missotten M; Cleva C; Dondi R; Ratinaud Y; Humbert Y; Mandal AB; Bombrun A; Power C; Chollet A; Proudfoot A
Bioorg Med Chem Lett; 2010 Jun; 20(12):3614-7. PubMed ID: 20483605
[TBL] [Abstract][Full Text] [Related]
2. Design and optimization of imidazole derivatives as potent CXCR3 antagonists.
Du X; Chen X; Mihalic JT; Deignan J; Duquette J; Li AR; Lemon B; Ma J; Miao S; Ebsworth K; Sullivan TJ; Tonn G; Collins TL; Medina JC
Bioorg Med Chem Lett; 2008 Jan; 18(2):608-13. PubMed ID: 18063364
[TBL] [Abstract][Full Text] [Related]
3. Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.
Wang Y; Busch-Petersen J; Wang F; Kiesow TJ; Graybill TL; Jin J; Yang Z; Foley JJ; Hunsberger GE; Schmidt DB; Sarau HM; Capper-Spudich EA; Wu Z; Fisher LS; McQueney MS; Rivero RA; Widdowson KL
Bioorg Med Chem Lett; 2009 Jan; 19(1):114-8. PubMed ID: 19014886
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.
Bongartz JP; Buntinx M; Coesemans E; Hermans B; Lommen GV; Wauwe JV
Bioorg Med Chem Lett; 2008 Nov; 18(21):5819-23. PubMed ID: 18922694
[TBL] [Abstract][Full Text] [Related]
5. Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.
Thoma G; Baenteli R; Lewis I; Wagner T; Oberer L; Blum W; Glickman F; Streiff MB; Zerwes HG
Bioorg Med Chem Lett; 2009 Nov; 19(21):6185-8. PubMed ID: 19783143
[TBL] [Abstract][Full Text] [Related]
6. Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists.
Cole AG; Stroke IL; Brescia MR; Simhadri S; Zhang JJ; Hussain Z; Snider M; Haskell C; Ribeiro S; Appell KC; Henderson I; Webb ML
Bioorg Med Chem Lett; 2006 Jan; 16(1):200-3. PubMed ID: 16213722
[TBL] [Abstract][Full Text] [Related]
7. Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists.
Watson RJ; Allen DR; Birch HL; Chapman GA; Hannah DR; Knight RL; Meissner JW; Owen DA; Thomas EJ
Bioorg Med Chem Lett; 2007 Dec; 17(24):6806-10. PubMed ID: 17964154
[TBL] [Abstract][Full Text] [Related]
8. Optimization of a series of quinazolinone-derived antagonists of CXCR3.
Liu J; Fu Z; Li AR; Johnson M; Zhu L; Marcus A; Danao J; Sullivan T; Tonn G; Collins T; Medina J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5114-8. PubMed ID: 19632842
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel series of potent S1P1 agonists.
Crosignani S; Bombrun A; Covini D; Maio M; Marin D; Quattropani A; Swinnen D; Simpson D; Sauer W; Françon B; Martin T; Cambet Y; Nichols A; Martinou I; Burgat-Charvillon F; Rivron D; Donini C; Schott O; Eligert V; Novo-Perez L; Vitte PA; Arrighi JF
Bioorg Med Chem Lett; 2010 Mar; 20(5):1516-9. PubMed ID: 20149651
[TBL] [Abstract][Full Text] [Related]
10. III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold.
Kim SH; Anilkumar GN; Zawacki LG; Zeng Q; Yang DY; Shao Y; Dong G; Xu X; Yu W; Jiang Y; Jenh CH; Hall JW; Carroll CD; Hobbs DW; Baldwin JJ; McGuinness BF; Rosenblum SB; Kozlowski JA; Shankar BB; Shih NY
Bioorg Med Chem Lett; 2011 Dec; 21(23):6982-6. PubMed ID: 22018463
[TBL] [Abstract][Full Text] [Related]
11. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.
Li AR; Johnson MG; Liu J; Chen X; Du X; Mihalic JT; Deignan J; Gustin DJ; Duquette J; Fu Z; Zhu L; Marcus AP; Bergeron P; McGee LR; Danao J; Lemon B; Carabeo T; Sullivan T; Ma J; Tang L; Tonn G; Collins TL; Medina JC
Bioorg Med Chem Lett; 2008 Jan; 18(2):688-93. PubMed ID: 18061451
[TBL] [Abstract][Full Text] [Related]
13. Imidazo-pyrazine derivatives as potent CXCR3 antagonists.
Du X; Gustin DJ; Chen X; Duquette J; McGee LR; Wang Z; Ebsworth K; Henne K; Lemon B; Ma J; Miao S; Sabalan E; Sullivan TJ; Tonn G; Collins TL; Medina JC
Bioorg Med Chem Lett; 2009 Sep; 19(17):5200-4. PubMed ID: 19631529
[TBL] [Abstract][Full Text] [Related]
14. I. Discovery of a novel series of CXCR3 antagonists. Multiparametric optimization of N,N-disubstituted benzylamines.
Bata I; Tömösközi Z; Buzder-Lantos P; Vasas A; Szeleczky G; Bátori S; Barta-Bodor V; Balázs L; Ferenczy GG
Bioorg Med Chem Lett; 2016 Nov; 26(22):5418-5428. PubMed ID: 27789137
[TBL] [Abstract][Full Text] [Related]
15. Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines.
Knight RL; Allen DR; Birch HL; Chapman GA; Galvin FC; Jopling LA; Lock CJ; Meissner JW; Owen DA; Raphy G; Watson RJ; Williams SC
Bioorg Med Chem Lett; 2008 Jan; 18(2):629-33. PubMed ID: 18068363
[TBL] [Abstract][Full Text] [Related]
16. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
[TBL] [Abstract][Full Text] [Related]
17. II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.
Shao Y; Anilkumar GN; Carroll CD; Dong G; Hall JW; Hobbs DW; Jiang Y; Jenh CH; Kim SH; Kozlowski JA; McGuinness BF; Rosenblum SB; Schulman I; Shih NY; Shu Y; Wong MK; Yu W; Zawacki LG; Zeng Q
Bioorg Med Chem Lett; 2011 Mar; 21(5):1527-31. PubMed ID: 21277198
[TBL] [Abstract][Full Text] [Related]
18. Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.
Thoma G; Baenteli R; Lewis I; Jones D; Kovarik J; Streiff MB; Zerwes HG
Bioorg Med Chem Lett; 2011 Aug; 21(16):4745-9. PubMed ID: 21764306
[TBL] [Abstract][Full Text] [Related]
19. Novel CXCR3 antagonists with a piperazinyl-piperidine core.
McGuinness BF; Carroll CD; Zawacki LG; Dong G; Yang C; Hobbs DW; Jacob-Samuel B; Hall JW; Jenh CH; Kozlowski JA; Anilkumar GN; Rosenblum SB
Bioorg Med Chem Lett; 2009 Sep; 19(17):5205-8. PubMed ID: 19647429
[TBL] [Abstract][Full Text] [Related]
20. IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.
Nair AG; Wong MK; Shu Y; Jiang Y; Jenh CH; Kim SH; Yang DY; Zeng Q; Shao Y; Zawacki LG; Duo J; McGuinness BF; Carroll CD; Hobbs DW; Shih NY; Rosenblum SB; Kozlowski JA
Bioorg Med Chem Lett; 2014 Feb; 24(4):1085-8. PubMed ID: 24486132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
